Optimization of combination therapy for chronic myeloid leukemia with dosing constraints
DOI10.1007/S00285-018-1262-6zbMATH Open1400.49058OpenAlexW2870320297WikidataQ89543368 ScholiaQ89543368MaRDI QIDQ1789085FDOQ1789085
Authors: Helen Moore, Lewis Strauss, Urszula Ledzewicz 
Publication date: 9 October 2018
Published in: Journal of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s00285-018-1262-6
Recommendations
- Optimization for the intensive treatment of leukemia
- Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
- An optimal strategy for leukemia therapy: a multi-objective approach
- Optimizing acute myelogenous leukemia treatment regimes via sequential structural mean models
- Optimal control of acute myeloid leukaemia
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- Design of personalized cancer treatments by use of optimal control problems: the case of chronic myeloid leukemia
- Optimal control for resistance and suboptimal response in CML
- Optimal therapy protocols in the mathematical model of acute leukemia with several phase constraints
constrained optimizationoptimal controlimmunotherapycombination therapychronic myeloid leukemia (CML)tyrosine kinase inhibitors (TKIs)
Medical applications (general) (92C50) Optimality conditions for problems involving ordinary differential equations (49K15) Variational principles of physics (49S05) Cell movement (chemotaxis, etc.) (92C17)
Cites Work
- Singular trajectories and their role in control theory
- Geometric optimal control. Theory, methods and examples
- Introduction to the mathematical theory of control
- Title not available (Why is that?)
- Modeling immunotherapy of the tumor -- immune interaction
- Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Optimal control in a model of dendritic cell transfection cancer immunotherapy
- Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost
- Diverse ideas on the growth kinetics of disseminated cancer cells
- Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations
- A mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy
- Optimal control of innate immune response
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- Optimal control for mathematical models of cancer therapies. An application of geometric methods
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
- A mathematical model of neutrophil production and control in normal man
- Optimal control applied to a generalized Michaelis-Menten model of CML therapy
- Mathematical modeling of cyclic treatments of chronic myeloid leukemia
Cited In (7)
- On the role of pharmacometrics in mathematical models for cancer treatments
- An optimization method for treating solid tumors with combined therapy using the great deluge algorithm
- On the role of the objective in the optimization of compartmental models for biomedical therapies
- An optimal strategy for leukemia therapy: a multi-objective approach
- Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
- Chemo and immunotherapy effects on stability regions of tumor models
- Optimal control of combination immunotherapy for a virtual murine cohort in a glioblastoma-immune dynamics model
This page was built for publication: Optimization of combination therapy for chronic myeloid leukemia with dosing constraints
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1789085)
